Entrepreneurship Innovation R&D
News 3 February, 2020

VIVEbiotech SL new member of the Board of Directors of the Spanish Bioindustry Association (AseBio)

AseBio brings together more than 730 companies that employ almost 100,000 people and invest more than € 400 million in R&D

AseBio brings together more than 730 companies that employ almost 100,000 people and invest more than € 400 million in R&D

After the last elections for the renewal of the governing bodies of AseBio, VIVEbiotech SL will occupy a seat in the new Board of Directors as Chair. AseBio brings together more than 730 companies that employ almost 100,000 people and invest more than € 400 million in R&D.

 

Its impact is 0.7% of GDP. The Gipuzkoan company believes that this fact demonstrates the trust of the rest of the partners in its project, and involves great responsibility and a great opportunity to work in the core of business decisions.

 

About VIVEbiotech

VIVEbiotech, located in the Gipuzkoa Science and Technology Park in San Sebastián, was created in 2015 and currently has a workforce of 37 people.

 

VIVEbiotech is in a growth phase with the objective of multiplying its production capacity by 30. To do so, it will build three new cleanrooms with large capacity bioreactors and plans to expand its workforce by 25%.

 

The company collaborates with world-class entities. The European Commission, through the EASME agency that analyzes the projects submitted to the “H2020-SME Inst-2016-2017” program, awarded the LENTISOMA project with the Seal of Excellence in competition with other European projects.

Related news

CIC biomaGUNE launches a company that will transform disease diagnosis by using nanosensors
18/02/2025 R&D

CIC biomaGUNE launches a company that will transform disease diagnosis by using nanosensors

Taldeki Biosolutions will be developing sensors for rapid, cost-effective, robust antibody detection, thus overcoming the stability and cost problems of current in vitro diagnostics

VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities
05/12/2024 Funding

VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities

Support the execution of a robust pipeline of customer projects for innovators developing groundbreaking in vivo and ex vivo cell and gene therapies.

CIC nanoGUNE launches a new call: Industry Collaborative Research Positions
09/05/2024 R&D

CIC nanoGUNE launches a new call: Industry Collaborative Research Positions

Programa honen helburua da ikertzaile profesionalak tokiko erakundeetan sar daitezen erraztea

Companies with greater gender equality perform better in terms of innovation and are more competitive
16/04/2024 Innovation

Companies with greater gender equality perform better in terms of innovation and are more competitive

The study of the SPRI initiative "Women in Industry" shows that gender equality has an impact on the improvement of company results.

SPRI presents the results of the study on the impact of women on industrial competitiveness at the World Manufacturing Forum
28/11/2023 Innovation

SPRI presents the results of the study on the impact of women on industrial competitiveness at the World Manufacturing Forum

The reports is the continuation of the work carried out by the SPRI Group and the Foreign Network office in Milan since 2020 as leader of the Women in Manufacturing expert group.

Go to the blog section

Follow us

Specialized channels and daily news on our social profiles.